Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective
- PMID: 23855464
- DOI: 10.1111/nyas.12150
Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective
Abstract
Primary prevention of cardiovascular disease (CVD) aims to avoid a first event in subjects that are at risk but have not yet been diagnosed with heart disease. Secondary prevention of CVD aims to avoid new events in patients with established heart disease. Both approaches involve clinical intervention and implementation of healthy lifestyles. The grape and wine polyphenol resveratrol (3,5,4'-trihydroxy-trans-stilbene) has shown cardioprotective benefits in humans. Most of these approaches deal with rather high doses and short follow-ups, and do not address the issue of long-term resveratrol consumption safety, especially in medicated individuals. Here, we review the trials conducted with resveratrol in patients at risk for or with established CVD, focusing on the two longest human clinical trials reported so far (1-year follow-up). We also discuss the expectations for resveratrol from a dietary and clinical perspective in relation to CVD. However, statistically significant changes in CVD-risk markers do not necessarily equal clinical significance in the daily care of patients.
Keywords: cardiovascular; clinical trial; grape; nutraceutical; polyphenol; resveratrol.
© 2013 New York Academy of Sciences.
Similar articles
-
One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease.Am J Cardiol. 2012 Aug 1;110(3):356-63. doi: 10.1016/j.amjcard.2012.03.030. Epub 2012 Apr 19. Am J Cardiol. 2012. PMID: 22520621 Clinical Trial.
-
The pig as a valuable model for testing the effect of resveratrol to prevent cardiovascular disease.Ann N Y Acad Sci. 2013 Jul;1290:130-5. doi: 10.1111/nyas.12216. Ann N Y Acad Sci. 2013. PMID: 23855475 Review.
-
Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.Mol Nutr Food Res. 2012 May;56(5):810-21. doi: 10.1002/mnfr.201100673. Mol Nutr Food Res. 2012. PMID: 22648627 Clinical Trial.
-
Interventions for cardiovascular disease prevention.Cardiol Clin. 2011 Feb;29(1):15-34. doi: 10.1016/j.ccl.2010.10.005. Cardiol Clin. 2011. PMID: 21257098 Review.
-
Commentary on 'resveratrol commonly displays hormesis: occurrence and biomedical significance' by Calabrese et al.Hum Exp Toxicol. 2010 Dec;29(12):1016-7. doi: 10.1177/0960327110383626. Hum Exp Toxicol. 2010. PMID: 21115560
Cited by
-
Dietary Phytoestrogens and Their Metabolites as Epigenetic Modulators with Impact on Human Health.Antioxidants (Basel). 2021 Nov 26;10(12):1893. doi: 10.3390/antiox10121893. Antioxidants (Basel). 2021. PMID: 34942997 Free PMC article. Review.
-
Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network.Elife. 2014 Apr 25;3:e02057. doi: 10.7554/eLife.02057. Elife. 2014. PMID: 24771768 Free PMC article.
-
Role of Dietary Antioxidants in the Preservation of Vascular Function and the Modulation of Health and Disease.Front Cardiovasc Med. 2017 Nov 1;4:64. doi: 10.3389/fcvm.2017.00064. eCollection 2017. Front Cardiovasc Med. 2017. PMID: 29164133 Free PMC article. Review.
-
Metabolic effects of resveratrol: addressing the controversies.Cell Mol Life Sci. 2015 Apr;72(8):1473-88. doi: 10.1007/s00018-014-1808-8. Epub 2014 Dec 30. Cell Mol Life Sci. 2015. PMID: 25548801 Free PMC article. Review.
-
Flavonoids and Related Members of the Aromatic Polyketide Group in Human Health and Disease: Do They Really Work?Molecules. 2020 Aug 24;25(17):3846. doi: 10.3390/molecules25173846. Molecules. 2020. PMID: 32847100 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources